LLY

1,083.98

+1.52%↑

JNJ

223.47

0%↓

ABBV

216.91

+0.4%↑

UNH

379.8

+1.05%↑

MRK

115.01

-1.25%↓

LLY

1,083.98

+1.52%↑

JNJ

223.47

0%↓

ABBV

216.91

+0.4%↑

UNH

379.8

+1.05%↑

MRK

115.01

-1.25%↓

LLY

1,083.98

+1.52%↑

JNJ

223.47

0%↓

ABBV

216.91

+0.4%↑

UNH

379.8

+1.05%↑

MRK

115.01

-1.25%↓

LLY

1,083.98

+1.52%↑

JNJ

223.47

0%↓

ABBV

216.91

+0.4%↑

UNH

379.8

+1.05%↑

MRK

115.01

-1.25%↓

LLY

1,083.98

+1.52%↑

JNJ

223.47

0%↓

ABBV

216.91

+0.4%↑

UNH

379.8

+1.05%↑

MRK

115.01

-1.25%↓

Strona główna・Stock List・Ascendis Pharma A/S
Search

Ascendis Pharma A/S

Open

SectorHealthcare

216.05 -0.17

Strong Buy

Price update 3 cze 2026, 19:25 UTC

BuySell

Overview

Share price change

24h

Current

Min

213.96

Max

217.14

Key metrics

By Trading Economics

Income

673M

640M

Sales

5.5M

251M

P/E

Sector Avg

27.27

50.102

EPS

0.27

Profit margin

255.205

Employees

1,189

EBITDA

15M

30M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+38.41% upside

Dividends

By Dow Jones

Next Earnings

6 sie 2026

Market Stats

By TradingEconomics

Market Cap

679M

15B

Previous open

216.22

Previous close

216.05

News Sentiment

By Acuity

50%

50%

147 / 344 Ranking in Healthcare

Ascendis Pharma A/S Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

2 cze 2026, 20:30 UTC

Earnings

Palo Alto Networks 3Q Revenue Rises as Customers Beef Up Cyber Defenses

DJ

Read

2 cze 2026, 23:58 UTC

Market Talk

Australia's Consumer Sector Expected to Be Stung by Housing Downturn -- Market Talk

DJ

Read

2 cze 2026, 23:46 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Read

2 cze 2026, 23:46 UTC

Market Talk

Nikkei May Rise as AI Demand Hopes Continue -- Market Talk

DJ

Read

2 cze 2026, 23:41 UTC

Market Talk

Oil Rises Amid Signs of U.S.-Iran Peace Talks Stalling -- Market Talk

DJ

Read

2 cze 2026, 23:01 UTC

Acquisitions, Mergers, Takeovers

ACCC Says Owner of Metro Petroleum Brand to Buy the 41 Sites

DJ

Read

2 cze 2026, 23:01 UTC

Acquisitions, Mergers, Takeovers

ACCC Says Ampol Must Sell 41 Retail Fuel Sites to an Approved Purchaser

DJ

Read

2 cze 2026, 23:00 UTC

Acquisitions, Mergers, Takeovers

Australia's Competition Regulator Approves Ampol's Purchase of EG Australia With Conditions

DJ

Read

2 cze 2026, 22:57 UTC

Market Talk

Australian Dollar Could Fall Following 1Q GDP Data -- Market Talk

DJ

Read

2 cze 2026, 22:50 UTC

Market Talk

Ulta Beauty Says TikTok Shop Will Provide 'Halo' Effect -- Market Talk

DJ

Read

2 cze 2026, 21:07 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Read

2 cze 2026, 21:07 UTC

Market Talk

Tokenized Assets Need Access to Digital-Finance Plumbing -- Market Talk

DJ

Read

2 cze 2026, 21:00 UTC

Earnings

Palo Alto Stock Jumps on Strong Earnings -- Barrons.com

DJ

Read

2 cze 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

DJ

Read

2 cze 2026, 20:46 UTC

Earnings

Palo Alto Stock Jumps on Strong Earnings -- Barrons.com

DJ

Read

2 cze 2026, 20:38 UTC

Earnings

GitLab Stock Rises as the Software Company Raises Guidance on AI Business Momentum -- Barrons.com

DJ

Read

2 cze 2026, 20:21 UTC

Earnings

Palo Alto Stock Jumps on Strong Earnings -- Barrons.com

DJ

Read

2 cze 2026, 20:12 UTC

Earnings

Palo Alto Stock Jumps on Strong Earnings -- Barrons.com

DJ

Read

2 cze 2026, 20:05 UTC

Earnings

Palo Alto Networks 3Q Product Rev $594M

DJ

Read

2 cze 2026, 20:05 UTC

Earnings

Palo Alto Networks Sees FY26 Next-Generation Security ARR $8.9B-$8.95B

DJ

Read

2 cze 2026, 20:05 UTC

Earnings

Palo Alto Networks Raises FY26 View To Adj EPS $3.77-Adj EPS $3.79 >PANW

DJ

Read

2 cze 2026, 20:05 UTC

Earnings

Palo Alto Networks 3Q Subscription and Support Rev $2.41B

DJ

Read

2 cze 2026, 20:05 UTC

Earnings

Palo Alto Networks Sees FY26 Remaining Performance Obligation $20.9B-$21B

DJ

Read

2 cze 2026, 20:05 UTC

Earnings

Palo Alto Networks Sees 4Q Rev $3.345B-$3.355B >PANW

DJ

Read

2 cze 2026, 20:05 UTC

Earnings

Palo Alto Networks Sees 4Q Adj EPS 96c-Adj EPS 98c >PANW

DJ

Read

2 cze 2026, 20:05 UTC

Earnings

Palo Alto Networks on Track to Achieve 40% Adj Free Cash Flow Margin in FY28

DJ

Read

2 cze 2026, 20:05 UTC

Earnings

Palo Alto Networks Raises FY26 View To Rev $11.415B-$11.425B >PANW

DJ

Read

2 cze 2026, 20:05 UTC

Earnings

Palo Alto Networks 3Q Remaining Performance Obligation $18.4B

DJ

Read

2 cze 2026, 20:05 UTC

Earnings

Palo Alto Networks 3Q Adj EPS 85c >PANW

DJ

Read

2 cze 2026, 20:05 UTC

Earnings

Palo Alto Networks 3Q Loss $177M >PANW

DJ

Read

Peer Comparison

Price change

Ascendis Pharma A/S Forecast

Price Target

By TipRanks

38.41% upside

12 Months Forecast

Average 302.86 USD  38.41%

High 355 USD

Low 255 USD

Based on 14 Wall Street analysts offering 12 month price targets forAscendis Pharma A/S - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

14 ratings

14

Buy

0

Hold

0

Sell

Based on 14 analysts giving stock ratings to Ascendis Pharma A/S - Dist in the past 3 months.

Sentiment

By Acuity

147 / 344 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

LLY

Eli Lilly and Co.

1,083.98

↑ +1.52%

JNJ

Johnson and Johnson

223.47

↓0%

ABBV

AbbVie Inc

216.91

↑ +0.4%

UNH

UnitedHealth Group Inc

379.8

↑ +1.05%

MRK

Merck & Co Inc.

115.01

↓-1.25%
help-icon Live chat